#Humantec hashtag - Bluesky

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - PHARMA - 10 February 2025 🔊Celltrion’s Avtozma Wins FDA Approval for Autoimmune & Inflammatory Diseases Avtozma, an Actemra biosimilar, is approved in both IV and SC forms, backed by a Phase III trial confirming its similarity...

Weekly Roundup - PHARMA - 10 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025 Highmark Health Expands Access to Stanza, FDA-Cleared Digital Therapy for Fibromyalgia Swing Therapeutics' digital treatment for fibromyalgia, Stanza, has received a positive coverage decision from Hi...

Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#HighmarkHealth #Stanza #DigitalHealth #HealthTech #Telemedicine #Telehealth #mHealth #HealthIT #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

UWA Researchers Secure $3M to Drive AI-Powered Digital Health Innovations The University of Western Australia (UWA) continues to solidify its reputation as a leader in digital health innovation, with eight of its researchers securing nearly $3 million in funding through the...

www.linkedin.com/pulse/uwa-re...

UWA Researchers Secure $3M to Drive AI-Powered Digital Health Innovations

kstrategyand.com/pharma-news

#UWA #DigitalHealth #AIHealthcare #PatientOutcomes #AudiologyTech #HealthTech #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

GSK Expands Cancer Portfolio with $1.15B Acquisition of IDRx, Eyeing Breakthrough GIST Therapy GSK has struck a deal to acquire IDRx, Inc., a Boston-based clinical-stage biopharmaceutical company, for up to $1.

www.linkedin.com/pulse/gsk-ex...

GSK Expands Cancer Portfolio with $1.15B Acquisition of IDRx, Eyeing Breakthrough GIST Therapy

kstrategyand.com/pharma-news

#GSK #IDRx #GIST #CancerTreatment #CancerCare #HealthcareInnovation #MedicalBreakthrough #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Kairos Pharma Secures $3.5 Million in PIPE Financing to Accelerate Growth Kairos Pharma, Ltd. (NYSE American: KAPA), a pharmaceutical company with a market cap of $22.

Kairos Pharma Secures $3.5 Million in PIPE Financing to Accelerate Growth

www.linkedin.com/pulse/kairos...

kstrategyand.com/pharma-news

#KairosPharma #PIPEFinancing #CancerResearch #PharmaceuticalGrowth #CancerTherapeutics #InvestmentDeal #BiotechInnovation #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - DIGITAL HEALTH/DTx - 4 February 2025

www.linkedin.com/pulse/weekly...

➡ kstrategyand.com/digital-heal...

#CareLoop #KAIST #UniversityOfMichigan #WHO #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - PHARMA - 3 February 2025 🔊AstraZeneca’s Calquence Wins FDA Approval as First-Line Treatment for Mantle Cell Lymphoma AstraZeneca’s Calquence (acalbrutinib) received FDA approval for first-line mantle cell lymphoma, showing a ...

🚀 Weekly Roundup - PHARMA - 3 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #Eisai #Biogen #Leqembi #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

AstraZeneca’s Calquence Gains Full Approval for Lymphoma, Faces Medicare Price Negotiations AstraZeneca has earned full FDA approval for its lymphoma treatment, Calquence, offering a significant step forward in the fight against mantle cell lymphoma (MCL). Originally granted accelerated appr...

www.linkedin.com/pulse/astraz...

AstraZeneca’s Calquence Gains Full Approval for Lymphoma, Faces Medicare Price Negotiations

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #InflationReductionAct #BTKInhibitor #MedicalBreakthrough #CancerResearch #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Retro Biosciences and OpenAI Join Forces to Tackle Aging with $1 Billion Investment San Francisco-based Retro Biosciences, a biotech start-up with a bold vision to extend human life by a decade, is gearing up for a $1 billion funding round to accelerate its ambitious mission. Backed ...

www.linkedin.com/pulse/retro-...

Retro Biosciences and OpenAI Join Forces to Tackle Aging with $1 Billion Investment

kstrategyand.com/pharma-news

#RetroBiosciences #OpenAI #AlzheimersTreatment #FutureOfMedicine #LifeExtension #Healthspan #AIandBiotech #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

FDA Approves Johnson & Johnson's SPRAVATO® as the First Monotherapy for Treatment-Resistant Depression in Adults Johnson & Johnson has just achieved a major breakthrough in the mental health space, with the approval of SPRAVATO® (esketamine) nasal spray as the first and only monotherapy for adults suffering from...

www.linkedin.com/pulse/fda-ap...

FDA Approves Johnson & Johnson's SPRAVATO® as the First Monotherapy for Treatment-Resistant Depression in Adults

kstrategyand.com/pharma-news

#SPRAVATO #FDAApproval #TRD #NewHopeForDepression #BreakthroughTreatment #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment AstraZeneca and Daiichi Sankyo have scored a significant win with the U.S.

www.linkedin.com/pulse/fda-gr...

FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment

kstrategyand.com/pharma-news

#AstraZeneca #DaiichiSankyo #HealthcareInnovation #ADCTherapy #TargetedTherapies #MedicalBreakthrough #CancerCare #Humanteconomy #Humantec

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Tuva Health’s Open-Source Approach to Healthcare Data Wins $5M in Seed Funding Tuva Health, an open-source healthcare data transformation platform, has officially emerged from stealth with a $5 million seed round and a bold vision to revolutionize the healthcare analytics indust...

www.linkedin.com/pulse/tuva-h...

Tuva Health’s Open-Source Approach to Healthcare Data Wins $5M in Seed Funding

kstrategyand.com/digital-heal...

#TuvaHealth #HealthcareAnalytics #HealthTech #EHR #HealthData #ClinicalResearch #TechForGood #DigitalHealth #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

SoriClear by NewLive: South Korea’s Fifth Digital Therapeutic Targets Tinnitus NewLive, an innovative startup founded by Professor Sang Jae-jun of Korea University Guro Hospital, has recently made waves in the medical field with the approval of its tinnitus treatment tool, SoriC...

www.linkedin.com/pulse/soricl...

SoriClear by NewLive: South Korea’s Fifth Digital Therapeutic Targets Tinnitus

kstrategyand.com/digital-heal...

#NewLive #SoriCLEAR #DigitalTherapeutics #TinnitusTreatment #AIHealthcare #GlobalHealth #MedicalBreakthrough #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - DIGITAL HEALTH/DTx - 28 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#NewLive #SoriCLEAR #CancerResearchUK #NIHR #EPSRC #Trinity #SUSA #DarioHealth #GLP1 #MediOrbis #KarolinskaInstitutet #NeurEYE #MedTech #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Weekly Roundup - PHARMA - 27 January 2025 🔊AstraZeneca's Calquence Gets Full FDA Approval for Mantle Cell Lymphoma Calquence becomes the first BTK inhibitor approved for first-line treatment of mantle cell lymphoma, offering a 27% progression...

🚀 Weekly Roundup - PHARMA - 27 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec

2 1 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

A New Era in Bladder Cancer Treatment: Pfizer’s Sasanlimab Hits the Mark Pfizer has unveiled groundbreaking Phase 3 results for its investigational PD-1 inhibitor, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG), a long-standing standard of care for high-ris...

www.linkedin.com/pulse/new-er...

A New Era in Bladder Cancer Treatment: Pfizer’s Sasanlimab Hits the Mark

kstrategyand.com/pharma-news

#Pfizer #Sasanlimab #BCG #CancerResearch #BladderCancerAwareness #NewTreatment #PharmaceuticalInnovation #HealthCare #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's Eli Lilly’s Omvoh® (mirikizumab-mrkz) has gained a significant regulatory nod, securing FDA approval for the treatment of moderately to severely active Crohn’s disease in adults. This marks a pivotal ...

www.linkedin.com/pulse/lilly-...

Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's

#Omvoh #EliLilly #CrohnsDisease #IBD #MedicalBreakthrough #ChronicIllness #Inflammation #PatientCare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand

1 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Karolinska Institute’s Digital Physiotherapy App Transforms Stroke Recovery with Nationwide Impact A breakthrough study from Karolinska Institute is redefining stroke rehabilitation by introducing a fully digital approach to physiotherapy that has proven highly effective and widely accessible. Publ...

www.linkedin.com/pulse/karoli...

Karolinska Institute’s Digital Physiotherapy App Transforms Stroke Recovery with Nationwide Impact

kstrategyand.com/pharma-news

#StrokeRecovery #DigitalPhysiotherapy #StrokeSurvivors #PhysiotherapyApp #SwedenHealthcare #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Tyra Biosciences Advances TYRA-300 to Phase 2 Trial for Bladder Cancer Treatment Tyra Biosciences, a cutting-edge clinical-stage biotechnology firm, has received a significant green light from the U.S.

www.linkedin.com/pulse/tyra-b...

Tyra Biosciences Advances TYRA-300 to Phase 2 Trial for Bladder Cancer Treatment

kstrategyand.com/pharma-news

#TyraBiosciences #TYRA300 #BladderCancer #CancerResearch #InnovationInMedicine #BladderCancerAwareness #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

FDA and MFDS Approve ImmunoForge’s Leading Drugs for DMD and CML, Accelerating Clinical Trials ImmunoForge, a pioneering biotech company, is making significant strides in the treatment of serious medical conditions with the recent approval of two Investigational New Drug (IND) applications by r...

www.linkedin.com/pulse/fda-mf...

FDA and MFDS Approve ImmunoForge’s Leading Drugs for DMD and CML, Accelerating Clinical Trials

kstrategyand.com/pharma-news

#ImmunoForge #FDAApproval #Pemziviptadil #DMDCardiomyopathy #PharmaceuticalNews #FDA #MFDS #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

FDA Greenlights Amgen’s Dual Therapy for KRAS G12C-Mutated Colorectal Cancer On January 16, 2025, the U.S.

www.linkedin.com/pulse/fda-gr...

FDA Greenlights Amgen’s Dual Therapy for KRAS G12C-Mutated Colorectal Cancer

kstrategyand.com/pharma-news

#FDAApproval #Amgen #Sotorasib #Panitumumab #ColorectalCancer #KRASG12C #CancerCare #HealthBreakthrough #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Cambridge and Cancer Research UK Unveil £10M AI-Powered Cancer Detection Programme In a groundbreaking effort to revolutionize cancer prevention and detection, Cambridge researchers are spearheading a £10 million initiative that promises to change how cancer is identified and manage...

www.linkedin.com/pulse/cambri...

Cambridge and Cancer Research UK Unveil £10M AI-Powered Cancer Detection Programme

kstrategyand.com/pharma-news

#CancerResearch #AIinHealthcare #HealthTech #PersonalizedMedicine #NHSInnovation #HealthcareRevolution #AIForGood #Humanteconomy #Humantec #KStrategyand

0 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal Eli Lilly and Co. is making waves in the oncology world with its bold move to acquire Scorpion Therapeutics' experimental PI3K inhibitor for a staggering $2.

www.linkedin.com/pulse/eli-li...

Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal

kstrategyand.com/pharma-news

#EliLilly #ScorpionTherapeutics #MedicalInnovation #Healthcare #PharmaPartnerships #Verzenio #BiotechNews #Humanteconomy #Humantec #KStrategyand

1 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025 The financial hub of San Francisco buzzed with anticipation as the prestigious JP Morgan Healthcare Conference unfolded, setting the stage for a series of transformative announcements that could resha...

www.linkedin.com/pulse/jp-mor...

JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025

kstrategyand.com/pharma-news

#HealthcareMergers #PharmaDeals #GSK #MergersAndAcquisitions #BiotechNews #Neuroscience #Oncology #Healthcare2025 #Humanteconomy #Humantec #KStrategyand

1 0 0 0

KStrategy&

@kstrategyand.bsky.social

1 year ago

FDA Approves AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan: A Breakthrough for Advanced Breast Cancer In a groundbreaking advancement for breast cancer treatment, the FDA has granted approval to datopotamab deruxtecan-dlnk, a Trop-2-directed antibody and topoisomerase inhibitor conjugate. Developed co...

www.linkedin.com/pulse/fda-ap...

FDA Approves AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan: A Breakthrough for Advanced Breast Cancer

kstrategyand.com/pharma-news

#FDAApproval #BreastCancerTreatment #DatopotamabDeruxtecan #MedicalAdvancements #Humanteconomy #Humantec #KStrategyand